Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0D6EW
|
|||
| Former ID |
DIB002987
|
|||
| Drug Name |
Glypromate
|
|||
| Synonyms |
Glycine-proline-glutamate (neuroprotectant), Neuren
Click to Show/Hide
|
|||
| Indication | Neurological disorder [ICD-11: 6B60] | Discontinued in Phase 2 | [1] | |
| Company |
Neuren Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | PI3K/AKT/mTOR pathway (PAm pathway) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021881) | |||
| REF 2 | Dendritic spine dysgenesis in Rett syndrome. Front Neuroanat. 2014; 8: 97. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.